Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy
Crossref DOI link: https://doi.org/10.1007/s10147-016-1032-7
Published Online: 2016-08-22
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ishihara, Hiroki
Yagisawa, Takafumi
Kondo, Tsunenori
Omae, Kenji
Takagi, Toshio
Iizuka, Junpei
Kobayashi, Hirohito
Tanabe, Kazunari
License valid from 2016-08-22